## LOW: Lowe's Companies, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 2.1% below STRENGTH zone (4.0-10.0%); PEG 2.18 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($237.60)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Lowe's Companies (LOW) Stock Price, Quote, News & History**
- Source: Benzinga | 20251210T040849 | Neutral | Relevance: 98%
-  This Benzinga article provides a comprehensive overview of Lowe's Companies (LOW) stock, including its current price, key statistics, recent news, financial performance, and analyst ratings. It details the company's market position as the second-largest home improvement retailer globally and lists its main competitors in the specialty retail sector. Investors can find information on upcoming dividends, earnings reports, and expert forecasts for LOW's price target.

**2. Lowe's Companies, Inc. to Host 2022 Analyst and Investor Conference on December 7th**
- Source: GuruFocus | 20251210T160841 | Somewhat-Bullish | Relevance: 97%
- Lowe's Companies, Inc. (NYSE: LOW) announced it will host its 2022 Analyst and Investor Conference on December 7th in New York City, providing updates on growth initiatives and long-term financial targets. A live webcast and replay will be available through the company's Investor Relations website.

**3. Is Now the Time to Buy Home Depot Stock at Its Current Price?**
- Source: TradingView | 20251211T140845 | Neutral | Relevance: 73%
-  Home Depot, a dominant force in the home improvement market, is currently navigating a soft demand environment, leading to a recent stock price decline. Despite this, its valuation remains elevated compared to the industry, and the company faces various risks including weaker demand visibility, margin pressure, and increased debt levels. While Home Depot is pursuing long-term growth strategies, the immediate outlook suggests a cautious approach for investors.

**4. Home Depot (HD) Stock Price, Quote, News & History**
- Source: Benzinga | 20251209T130815 | Neutral | Relevance: 70%
-  This article provides a comprehensive overview of Home Depot (HD) stock, including its current price, key statistics, recent news, and analyst ratings. It highlights the company's reaffirmation of its outlook and strategic priorities, betting on a housing recovery to drive growth, as well as an analyst's anticipation of an earnings rebound.

**5. What's Going On With Home Depot Stock Tuesday? - Home Depot (NYSE:HD)**
- Source: Benzinga | 20251209T131532 | Neutral | Relevance: 66%
-  Home Depot will use its 2025 Investor and Analyst Conference to reaffirm its fiscal 2025 outlook and establish an early baseline for fiscal 2026, including a scenario anticipating a housing-led demand increase. The company reiterated its fiscal 2025 expectations, projecting approximately 3% total sales growth and a 6% diluted EPS decline. For fiscal 2026, Home Depot foresees comparable sales ranging from flat to up 2%, with a "Market Recovery Case" anticipating higher sales and EPS growth driven by an improved housing market.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 10)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Oppenheimer | $315 | $320 | -2% |
| 2025-12-01 | Stifel | $250 | $230 | +9% |
| 2025-11-20 | UBS | $316 | $325 | -3% |
| 2025-11-20 | JP Morgan | $300 | $275 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Oppenheimer | main | Outperform |
| 2025-12-01 | Stifel | main | Hold |
| 2025-11-20 | UBS | main | Buy |
| 2025-11-20 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 7 ($0.41M) |
| Sells | 1 ($0.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 13.4% (+138.6%)
- Vanguard Group Inc: 9.9% (+0.6%)
- Blackrock Inc.: 7.0% (-0.3%)
- FMR, LLC: 4.6% (-3.7%)
- State Street Corpora: 4.5% (+0.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 4 raises (avg +6%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.18 elevated, pricing in significant growth expectations. Forward P/E 19.1x stretched relative to 6% growth. Quality metrics strong (ROA 13%). Analyst sentiment negative (10 target cuts vs 4 raises). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $139.2B |
| Beta | 0.96 |
| 52W Range | $206.39 - $274.98 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.18 |
| Forward P/E | 19.1 |
| Current P/E | 20.2 |
| YoY Growth | 6.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-1.0% over 5 days). Below STRENGTH zone by 1.9pp (needs >4.0% for momentum thesis). MRS_5 at 0.8% confirms short-term momentum alignment. AM_20 at 4.3% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.27), confirming momentum. RSI neutral at 59.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.08% (CS: 60) | Neutral |
| RSI_14 | 59.1 | Neutral |
| MACD Histogram | 1.27 | Bullish |
| vs SMA20 | 1.043x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 1.053x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $248.08
- **Stop Loss:** $237.60 (4.2% risk)
- **Target:** $258.56 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 131
- **Position Value:** $32,498.48
- **Portfolio %:** 32.50%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-25 (Est: $1.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.95 | $3.06 | +3.6% |
| 2025Q3 | $4.24 | $4.33 | +2.2% |
| 2025Q2 | $2.88 | $2.92 | +1.4% |
| 2025Q1 | $1.84 | $1.93 | +4.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*